medicines

Since 2018, the Company has acquired various specialty care medicines, including several treatments in hematology and oncology.

Report adverse events or product complaints to pharma& at pv@pharmaand.com.

For medical information inquiries outside of the U.S., contact pharma& at medinfo@pharmaand.com.

For medical information inquiries within the U.S., contact pharma& at medinfo.us@pharmaand.com.

The information below is intended for healthcare providers.

Anafranil

Anafranil® (clomipramine hydrochloride)

Psychiatric Disorders

Reference:
For all EU and EEA countries
For non-EU countries please refer to your local health authority website.

Androskat
Androskat® (papaverine hydrochloride/phentolamine mesylate)

Urology

Reference:
Netherlands

Asacol

Asacol® (mesalazine)

Gastroenterology

Reference:
Netherlands

Dridase

Dridase® (oxybutynin hydrochloride)

Urology

Reference:
For all EU and EEA countries

Emselex

Emselex® (darifenacin hydrobromide)

Urology

Reference:
EPAR (last updated 24/05/2013)
SmPC – Product Information (last updated 30/09/2023)

Euphyllin

Euphyllin® (theophylline anhydrous capsule)

Cardiovascular and Pneumology

Reference:
CZ, PL, SK, ES: please refer to your local health authority’s website. 

Faktu

Faktu® (policresulen cinchocaine hydrochloride)

Anorectal Disorders

Reference:
CZ, SK, SI, HR, PT please refer to your local health authority’s website.

Farydak
Farydak® (panobinostat)

Hematology

Reference:
EPAR (last updated 16/05/2023)
SmPC – Product Information (last updated 30/09/2023)
For further information on Farydak, please go to: https://global.farydak.com/

Levact

Levact® (bendamustine)

Hematology

Reference:
For all EU and EEA countries
For non-EU countries please refer to your local health authority website.

Pegasys

Pegasys® (peginterferon alfa-2a)

Immunostimulant

Reference:
EPAR (last updated 20/07/2022)
SmPC – Product Information (last updated 30/09/2023)
For non-EU countries please refer to your local health authority
For U.S.A. n.a.
For Canada – As previously supplied by Hoffmann-La Roche Limited, the pre-filled syringe is the only Pegasys® format available from pharmaand GmbH and Accelera Pharma Canada Inc.
Pour le Canada – La seringue préremplie Pegasys®, fournie auparavant par Hoffmann-La Roche Limited, est l’unique présentation disponible auprès de pharmaand GmbH et Accelera Pharma Canada Inc.

Rubraca

Rubraca® (rucaparib)

Oncology

Reference:
EPAR (last updated 30/11/2023)
SmPC – Product Information (last updated 15/2/2024)
For other non-EU countries, please refer to your local health authority
For U.S.A. USPI (last updated 06/2023) or visit www.rubracahcp.com